<code id='C2701DD324'></code><style id='C2701DD324'></style>
      • <acronym id='C2701DD324'></acronym>
      <center id='C2701DD324'><center id='C2701DD324'><tfoot id='C2701DD324'></tfoot></center><abbr id='C2701DD324'><dir id='C2701DD324'><tfoot id='C2701DD324'></tfoot><noframes id='C2701DD324'>
      • <optgroup id='C2701DD324'><strike id='C2701DD324'><sup id='C2701DD324'></sup></strike><code id='C2701DD324'></code></optgroup>
        5. <b id='C2701DD324'><label id='C2701DD324'><select id='C2701DD324'><dt id='C2701DD324'><span id='C2701DD324'></span></dt></select></label></b><u id='C2701DD324'></u>
          <i id='C2701DD324'><strike id='C2701DD324'><tt id='C2701DD324'><pre id='C2701DD324'></pre></tt></strike></i>
           
   
   
   
 

  
           
   
           
    
           
     
          
       Home / comprehensive / knowledge      
           
     
           
      
          knowledge 
           
      
           
      
           
       2025-09-28 18:53:04 
   
      
           
      
           
                        
          knowledge  
          
                                   
                 
                                      author：comprehensive   
                                        
                                      
                                      Page View：475
                                  
                                    
          
                                   
          Editor’s note: A recording of the event is embedded below.
          After a few go-go years, the early-stage biotech market has cooled considerably. Two VCs will weigh in on what distinguishes great science from bad investments.
          advertisement
          Featured Speakers
          • Irena Melnikova, Ph.D., partner, Pfizer Ventures
          • Rakhshita Dhar, senior director, venture investments, Leaps by Bayer
          • Frank S. David, M.D., Ph.D., managing director, Pharmagellan (moderator)
          Get unlimited access to award-winning journalism and exclusive events.					
          Subscribe																						Log In															
                      
                              
          
                                 Previous article：

                                
                                          'Null' research findings aren't empty of meaning. Let's publish them
                                
                            
          Next article：  
                                      
                                          Hepatitis C has a cure — but many Americans still lack access to it
                                                                    
          

      
           
    


       
       
       
    
     
           
    
           
    
           
   
      
     
           
      
           
       
          Related articles